China Pharma (NYSE:CPHI) Coverage Initiated at

Research analysts at started coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $0.26 on Tuesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.25 and a current ratio of 0.89. The stock’s 50 day moving average is $0.28 and its 200 day moving average is $0.37. China Pharma has a twelve month low of $0.24 and a twelve month high of $1.95.

China Pharma (NYSE:CPHIGet Free Report) last issued its earnings results on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The business had revenue of $1.37 million for the quarter.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Read More

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with's FREE daily email newsletter.